Arcadia Biosciences, Inc. (RKDA)

Market Cap	1.81M -69.3%
Revenue (ttm)	4.76M -9.5%
Net Income	-9.32M
EPS	-6.03
Shares Out	2.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	275,874
Open	0.8500
Previous Close	0.9059
Day's Range	0.8221 - 0.9194
52-Week Range	0.7740 - 6.7100
Beta	0.52
Analysts	Strong Buy
Price Target	12.00 (+1,263.64%)
Earnings Date	May 14, 2026

About RKDA

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

• Industry: Packaged Foods
• Sector: Consumer Staples
• IPO Date: May 15, 2015
• Employees: 8
• Stock Exchange: NASDAQ
• Ticker Symbol: RKDA
• Website: https://arcadiabio.com

Financial Performance

In 2025, Arcadia Biosciences's revenue was $4.86 million, a decrease of -3.71% compared to the previous year's $5.05 million. Losses were -$2.34 million, -66.77% less than in 2024.

Analyst Summary

According to one analyst, the rating for RKDA stock is "Strong Buy" and the 12-month stock price target is $12.0.

Price Target

$12.0

(1,263.64% upside)

Analyst Consensus: Strong Buy